Sun Pharmaceuticals founder Dilip Shanghvi and his associates have purchased a 23% stake in Suzlon Energy.[ihc-hide-content ihc_mb_type=”show” ihc_mb_who=”3″ ihc_mb_template=”2″ ]The deal was valued at approximately ₹18 billion (US$286 million) with an additional open offer size of approximately ₹28 billion, making it one of the largest acquisitions in recent years.
Finsec Law Advisors advised the manager to the open offer.
PH Bathiya & Associates advised the acquirers.
[/ihc-hide-content]
